Inhibition of EGFR signaling with Spautin-1 represents a novel therapeutics for prostate cancer

BACKGROUND: Prostate cancer (PCa) remains a challenge worldwide. Due to the development of castration-resistance, traditional first-line androgen deprivation therapy (ADT) became powerlessness. Epidermal growth factor receptor (EGFR) is a well characterized therapeutic target to treat colorectal car...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Yuning, Guo, Zhiqiang, Xia, Xiaohong, Liu, Yuan, Huang, Chuyi, Jiang, Lili, Wang, Xuejun, Liu, Jinbao, Huang, Hongbiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460657/
https://www.ncbi.nlm.nih.gov/pubmed/30975171
http://dx.doi.org/10.1186/s13046-019-1165-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460657/
https://www.ncbi.nlm.nih.gov/pubmed/30975171
http://dx.doi.org/10.1186/s13046-019-1165-4

Ejemplares similares